Investigative cancer treatment research facility Seattle Genetics is very popular right now. The CEO and President of the company is Clay Siegall. He is also the co-founder of the company, which was established in 1998. Dr. Siegall also sits on the committee board as their chairman. Since the beginning of his career as a biomedical investigator, he has an extensive history of going above and beyond what is required to help patients who suffer from cancer. His co-workers confess that they consider Dr. Siegall to be a diligent and committed doctor, who has guided the company towards applying advances in treating cancer patients, and the use of advanced therapies for cancer patients.
Dr. Siegall’s commitment to researching cancer therapies is well-known. He makes use of the most current, highly developed techniques, which are exemplified in the creation of antibody-drug conjugates. This advancement earned Seattle Genetics an endorsement from the FDA in 2011. As they expanded their company, they became capable of assisting cancer survivors worldwide.
The College of Maryland awarded Dr. Siegall with the esteemed Alumnus of the Year in 2013 for Math and Natural Sciences. Seattle Genetics is the recipient of a $1.2 billion donation, which was raised by the efforts of Dr. Siegall. This surplus of revenue aided in the establishment of highly advanced techniques to assist survivors of cancer, by purchasing cutting-edge technology.
The George Washington University granted Dr. Siegall his Ph.D., in the field of Genetics. Following this achievement, Dr. Siegall began his career as a Senior Researcher at the Pharmaceutical Investigate Institute, which is owned by Bristol-Myers. He soon earned the accolade of becoming the Foremost Scientist from the National Cancer Organization, and he was further honored with the status of Staff Fellow and Biotechnology Fellow. Such well honored recognition for his commitment fueled his ambition to contribute to the scientific community with the publishing of advanced therapies for cancer survivors. Dr. Clay Siegall also brought to fruition his desire to found his own company, Seattle Genetics. That company’s stock evaluations have tripled in value within a 5 year period.